ISIN | IE00B39YK708 |
---|---|
Valor Number | 4413092 |
Bloomberg Global ID | WGHCEQT ID |
Fund Name | Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund GBP T AccU |
Fund Provider |
Wellington Management Company LLP
Web: https://www.wellingtonfunds.com |
Fund Provider | Wellington Management Company LLP |
Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
Distributor(s) | Wellington Global Administrator, Ltd. |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Peculiarities |
Current Price * | 103.54 GBP | 22.11.2024 |
---|---|---|
Previous Price * | 102.07 GBP | 21.11.2024 |
52 Week High * | 111.83 GBP | 30.08.2024 |
52 Week Low * | 90.79 GBP | 28.11.2023 |
NAV * | 103.54 GBP | 22.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,757,443,111 | |
Unit/Share Assets *** | 15,268,663 | |
Trading Information SIX |
YTD Performance | +3.56% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +8.13% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -5.03% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -7.96% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -2.71% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +10.84% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +4.80% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +6.96% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +42.20% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 8.90% | |
---|---|---|
UnitedHealth Group Inc | 7.18% | |
Novo Nordisk A/S | 5.18% | |
AstraZeneca PLC | 4.53% | |
Merck & Co Inc | 4.44% | |
Danaher Corp | 2.82% | |
Boston Scientific Corp | 2.66% | |
Novartis AG Registered Shares | 2.57% | |
Intuitive Surgical Inc | 2.37% | |
argenx SE | 2.35% | |
Last data update | 30.09.2024 |
TER | 0.08% |
---|---|
TER date | 15.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.08% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |